Complying with regulations, and improving ADR reporting and risk management for safer drugs in Asia

Pharmacovigilance Asia conference provides a platform connecting regulatory authorities and industry professionals. Take a look at the latest delegates list:

  • ASEAN Secretariat
  • Abbott India Limited
  • Alcon Laboratories
  • All India Institute of Medical Sciences
  • Astellas
  • AstraZeneca KK Pharmaceuticals - アストラゼネカ株式会社
  • AstraZeneca Singapore Private Limited
  • Bausch & Lomb
  • Bausch & Lomb (S) Private Limited
  • Baxter Healthcare (Ltd)
  • Baxter India Private Limted
  • Bayer HealthCare Global R&D Center
  • Bayer Healthcare
  • Bayer South East Asia Private Limited
  • Boehringer Ingelheim
  • Boehringer Ingelheim International
  • CSL Australia Pty Ltd
  • Celgene Private Limited
  • Daiichi Sankyo Taiwan Limited
  • Danish Medicines Agency
  • Div. of Johnson & Johnson Pharmaceutical R&D
  • EXTEDO GmbH
  • Eisai Company Limited
  • Eli Lilly Japan k K
  • European Commission
  • Food and Drug Administration
  • Fresenius Kabi Oncology Limited
  • GlaxoSmithKline China R&D Company Limited
  • Guerbet Asia Pacific Ltd
  • Hospira Philippines Inc.
  • Glenmark Pharmaceuticals Limited
  • Invida
  • Ipsen International
  • Kinapse Ltd
  • Lundbeck Singapore Pte. Ltd
  • Merck Sharp and Dohme Australia
  • Ministry of Health
  • Nagase Singapore Pte Ltd
  • Novartis Singapore Private Limited
  • PHAREX HealthCorp
  • PV Center Unit
  • Pfizer Limited
  • Pharmaceutical Society of Singapore
  • Philippines Food and Drug Administration
  • Sanofi-Aventis Malaysia
  • Sanofi-Aventis Singapore
  • Sanofi-aventis(China) Investment Co Ltd, Shanghai Branch
  • Servier (Beijing) Pharmaceutical Research & Development Co., Ltd
  • Servier (S) Pte. Ltd.
  • Shanghai Center for Adverse Drug Reaction Monitoring, SFDA
  • Shanghai Roche Pharmaceuticals Limited
  • Solvay Pharma India Limited
  • Solvay Pharmaceuticals
  • Taiho Pharmaceutical Co. Ltd
  • Taiwan FDA
  • Takeda Pharmaceuticals
  • Therapeutical Goods Administration
  • Uppsala Monitoring Centre

sponsor_hdr

media_hdr

supporting

Regulatory updates from

  • Patrick-DEBOYSER
    Patrick Deboyser
    Advisor in the Directorate General for Health and Consumers
    European Commission
     Shirley-V-Ramesh
    Shirley Ramesh
    Senior Officer, Standards and Conformance Unit, Trade and Facilitation Division, Market Integration Directorate
    ASEAN Secretariat
    nospeaker
    Shinichi Nishiuma
    Vice Chairperson
    Japanese Association of Pharmaceutical Medicine
  • Dorisbillede
    Doris Stenver
    Chief Medical Officer, Consumer Safety Division, Danish Medicines Agency
    Member of European Pharmacovigilance Working Party
     nospeaker
    Dr. Jane Cook
    Head (Acting) Office of Product Review
    Therapeutic Goods Administration Australia
    nospeaker
    Dr. Du Wenmin
    Executive Director
    Shanghai Center for Adverse Drug Reaction Monitoring, SFDA
  • nospeaker
    Suzette H Lazo
    Director
    FDA Philippines
    wimon
    Wimon Suwankesawong
    Head of Health Product Vigilance Center
    FDA Thailand
    Khalid-Zolkipli
    Mohamad Khalid Haji Zolkipli
    National Adverse Drug Reaction Monitoring Centre, Department of Pharmaceutical Services, Ministry of Health
    Brunei Darussalam
  • Y-K-Gupta
    Dr. Y K Gupta
    Coordinator
    National Pharmacovigilance Programme, India
    MaryTai
    Mary Tai
    Senior Specialist, Division of Drug and New Biotechnology Products
    Taiwan FDA

View all speakers

21 Market insights and case studies from

  • nospeaker
    Songlin Xue
    Senior Vice President and Global Head of Pharmacovigilance
    Takeda Pharmaceuticals International
    nospeaker
    Dr. Stewart Geary
    Vice President
    Eisai Co.
    Jean-Christophe-Delumeau
    Jean-Christophe Delumeau
    Head of Pharmacovigilance Asia-Pacific
    Bayer Healthcare Global R&D Center
  • nospeaker
    Rachel Wong
    Global Safety & Vigilance Manager - APAC
    Bausch & Lomb
     nospeaker
    Vivek Ahuja, MD
    Director, Pharmacovigilance - Asia Pacific
    Baxter Healthcare
    nospeaker
    Dr. Satoshi Yamanaka
    Head of Pharmacovigilance
    Bayer Yakuhin
  • PhuaChweePingCrop
    Chwee Ping Phua
    Head Pharmacovigilance Operations, AMAC
    Novartis Asia Pacific Pharmaceuticals
    Irene
    Irene Rebollo
    Head of Medical Safety International
    Alcon Laboratories
    nospeaker
    Victoria Elegant
    VP Regulatory Affairs and Pharmacovigilance
    Asia-Pacific, Baxter Healthcare
  • nospeaker
    Joy Li
    Director, Pharmacovigilance and Medical Governance Development
    GlaxoSmithKline
    GeraldinePetersonClark
    Geraldine Peterson-Clark
    Medical Affairs Team Leader
    Boehringer Ingelheim
    Michael-Borawski
    Michal Borawski
    International Pharmacovigilance Officer
    Sanofi Pasteur
  • nospeaker
    Rashmi Hedge
    Director Pharmacovigilance, Asia-Middle East-Australia- Canada, Global Pharmacovigilance & Risk Management
    Abbott Products
    dannyheadandshoulders
    Danny Hodder
    Regional Director Asia Pacific, Global Security
    AstraZeneca
     nospeaker
    Wang Yuhong
    Drug Safety Manager, Safety Operation
    Roche Product Development
  • nospeaker
    Herman Schwietert
    General Manager China
    Invida
     nospeaker
    Jessica Thongcharen
    Pharmacovigilance Country Head, Singapore/Brunei
    Bayer Southeast Asia
    nospeaker
    Dr. Marli Watt
    Head of Risk Management,
    CSL Limited
  • nospeaker
    Kristy Van Dinther
    Clinical Science Specialist
    CSL Limited
    nospeaker
    Dr. Raymond Lowing
    Senior Expert
    ADN
     Humaira-Qureshi
    Humaira Qureshi
    Senior Manager Pharmacovigilance
    Kinapse
  • Humaira-Qureshi
    Humaira Qureshi
    Senior Manager Pharmacovigilance
    Kinapse

View all speakers

 
Choose your language
Japanese Traditional Chinese Simplified Chinese Korean

Register Now

Register and pay by 1 July 2011 and receive up to SG$1000 off!

Brochure

Resource Centre

Visit the Download Centre for FREE industry related content:

stayconnected_btn

calendar

Mark Your Calendar

Reminder for this event

colleague

Tell a Colleague


Forward this event

Pharma IQ

Become a Pharma IQ Member and receive our weekly newsletter!

Connect to a global Pharma IQ social network

  • Linkedin

    Linkedin

  • Twitter

    Twitter

  • Facebook

    Facebook

testimonial_hdr

"The IQPC Pharmacovigilance conference in Singapore, which is becoming an annual event is, to my knowledge, the most comprehensive information exchange and discussion forum dedicated to pharmacovigilance held in Asia so far". Jean-Christophe Delumeau, Head of Pharmacovigilance Asia-Pacific, Bayer Healthcare Global R&D Center
“Had an overall understanding of pharmacovigilance running in Asia, particularly in ASEAN. It is helpful for me to make a plan locally and accelerate pharmacovigilance strategy locally” Aileen Li, Director of Regulatory Affairs, Nycomed China
“Good discussions, good comments from all representatives and speakers” Tay Hui Hui, CPM, EPS International
“Good forum to discuss Asia Pacific regulations. Good networking. Opportunity to set up a pharmacovigilance working group in this region” Balasubramanian Sankaranarayanan, Head of UFESCIENCES EU & APAC, Cognizant